Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

BIO-Europe 11/7

posted on Nov 06, 2017 10:52AM

BIO-Europe tomorrow 11/7 in Berlin. Zenith presents at 3:15 PM local time and Resverlogix presents at 4:45 PM local time (both as of the online schedule this morning). Zenith's webpage indicates that its presentation will be made available at the time of live presentation. I imagine Resverlogix will do the same. Both presentations will be over 24 hours from now. Hopefully we'll have some new info to discuss.

BearDownAZ

2 Recommendations

Re: BIO-Europe 11/7

Hartland

Nov 07, 2017 09:58AM